Revvity | PKI - 流动资产

股票价格
86.77
每天变化
-0.38 -0.44%
每月一次
-1.22%
每年
-7.98%
Q2 预测
84.91


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.68B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


流动资产 更改 日
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Celltrion KRW 5.54T 291.68B 2025-09
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Edwards Lifesciences USD 6.74B 380M 2025-12
Illumina USD 3.29B 493M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
IQVIA Holdings USD 6.25B 270M 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.45B 80.6M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Tilray USD 729.32M 28.18M 2025-09
Waters USD 1.99B 69.86M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09